Introduction
Salmon aquaculture industry has rapidly expanded over the last decades with Norway and Chile being the main contributors. With this rapid growth, it has encountered alarms over environmental impacts and sustainability. Among the sustainability issues are factors affecting fish welfare and health including sea lice and disease outbreaks leading to chemical and antibiotic usage in some regions of global salmon farming. A ntibiotic usage could lead to issues and concerns over the development of antibiotic resistance and undesirable effects on the host. Several studies have reported the presence of antibiotic resistant bacteria and/or antibiotic resistant genes in intestine of medicated fish and healthy fish, farm ing and non-farming sites indicting the significance of the antibiotic resistance related to salmon aquaculture industry. Antibiotics can trigger perturbations in host gut microbiome resulting in dysbiosis, leading to detrimental health effects. Even though, a few studies have reported the p erturbations in gut microbiota of Atlantic salmon caused by some antibiotics, in depth understanding of antibiotic-induced dysbiosis and related health and physiological effects are lacking.
Synbotic , a mixture of probiotic and prebiotic agents, exerts beneficial affects to the host by increasing the survival and activity of probiotics and indigenous health promoting bacteria in the gut. Several previous studies described the beneficial effects of synbiotics on salmonoids . Mammalian studies showed concomitant use of probiotics , prebiotics and synbiotics with antibiotics could re-establish gut microbiota and prevent antibiotic resistance and antibiotic associated gastrointestinal disorders. However, the use of pre- pro- or synbiotics to assess similar effects in fish are scanty.
The present study attempted to address those research gaps by evaluating the effects of synbiotic diets on re-establishment of the Atlantic salmon gut microbiota after dysbiosis triggered by medicated feeds.
Materials and methods
Systematic representation of experimental design , experimental procedure and expected outcome is illustrate d in the Figure 1. Post-smolt Atlantic salmon were fed with a control commercial diet and a synbiotic diet in which the commercial diet was supplemented with 0.04% Pediococcus acidilactici and 0.1% scFOS , for a period of five weeks. Each of the feed group had five pens. After the acclimatization period, fish in the three out of five pens in each of the groups were fed with medicated feeds containing either control diet + florfenicol (3.5ppm) or synbiotic diet + florfenicol (3.5ppm) for a period of two weeks. Then those fish were re- fed with their respective non-medicated diets i.e control or synbiotic diets, for another six weeks. The fish in the remaining two pens from each group were continuously fed with control or synbiotic diets until the end of the feeding trial.
Fish used for microbiota analysis were pit-tagged and d igesta samples were collected at the start and end of the medicated feeding and end of the re-feeding period. Microbiota analysis was performed with 16S rRNA sequencing and subsequent bioinformatics analysis were carried out using QIIME2. Growth performance, histomorphology and transcriptomic changes were also evaluated .
Results and Discussion
Treatment with antibiotics negatively affected the thermal growth coefficient in both the control and synbiotic diet fed groups. However , the reduction in growth wa s less in the synbiotic group compared to the control group. Analysis of microbiota data is currently in progress and will be presented in the conference . We are expected to see that a ntibiotic treatment related perturbations in digesta-associated microbiota in both the groups. Moreover, we hypothesized that t he fish fed with synbiotic fee d would indicate rapid re-establishment of intestinal microbiota within a period of six weeks or earlier. Further, it was al so hypothesized that t his rapid maintenance of intestinal microbiota may positively impact in the reduction of the growth loss observed in those fishes. The knowledge generated in this study could be further explored to improve antibiotic related dysbiosis in gut microbiota and related physiological impacts in Atlantic salmon aquaculture industry.